https://www.selleckchem.com/pr....oducts/eeyarestatin-
9% and 85.9%, respectively (p=0.00019). In the patients with high MSLN expression, the conversion rate among those with initially unresectable metastases was 0% versus 14% in the patients with low MSLN expression (p=0.0053). The median overall survival (OS) was 1.5 years (95% confidence interval [CI] 1.1-2.8) in the high MSLN expression group versus 2.6 years (95% CI 2.2-3. in the low MSLN expression group. The 3-year OS rates in these groups were 23.5 and 41.5%, respectively (p=0.012. High MSLN expression is correlated with
Like
Comment
Share
